{
    "2019-04-24": [
        [
            {
                "time": "",
                "original_text": "【医药】002821*凯莱英:Q1同比改善业绩高增长，全年更亮眼表现可期*买入",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "Q1",
                        "同比改善",
                        "高增长",
                        "买入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英:Q1维持高速增长,行业保持高景气度",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "Q1",
                        "高速增长",
                        "高景气度"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}